OALC OneAscent Large Cap Core ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 7.41% |
| MSFT | 5.21% |
| AMZN | 3.90% |
| GOOGL | 3.15% |
| GOOG | 2.60% |
| AVGO | 2.52% |
| JPM | 1.75% |
| CSCO | 1.71% |
| XOM | 1.66% |
| LLY | 1.60% |
ETF Analysis
Fund Overview
OneAscent Large Cap Core ETF (OALC) currently reports 205 stock positions (subject to change), placing it in the widely diversified range by holdings breadth. The top line-up is NVDA (7.41%), MSFT (5.21%), AMZN (3.90%), with NVDA as the largest single weight at 7.41%. Together, the top three holdings account for 16.52%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 32.19%, WACC is 9.42%, and the economic spread is 22.77%. On balance, ROIC clears WACC by a meaningful margin, suggesting the portfolio's holdings are creating rather than consuming intrinsic value. Supporting metrics show ROE at 39.10% and ROA at 12.73%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
On an earnings multiple basis, trailing P/E of 25.75, forward P/E of 19.24, PEG of 1.80. The spread between trailing and forward P/E is moderate, suggesting some earnings improvement is expected but not a dramatic re-rating. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio of 1.74 suggests the holdings have sufficient short-term liquidity without excess. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 56.50%, operating margin at 28.73%, and free cash flow margin at 22.48%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, the underlying holdings demonstrate good cash generation relative to the revenue base. Together, these margin readings describe a portfolio of businesses that protect profitability at every layer of the income statement.
Growth & Forward Outlook
Connecting operational trends with market expectations, TTM revenue growth of 19.98% indicating steady top-line growth at the portfolio level, while the estimated 12-month price change of 22.26%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 33.9%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.